Mutagrip sospensione iniettabile

Land: Sveits

Språk: italiensk

Kilde: Swissmedic (Swiss Agency for Therapeutic Products)

Aktiv ingrediens:

haemagglutininum influenzae di tipo A (H1N1) (ceppo del Virus A/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275), haemagglutininum influenzae A (H3N2) (ceppo del Virus A/Singapore/INFIMH-16-0019/2016 (H3N2)-come: reassortant virus IVR-186), haemagglutininum influenzae B (Virus del ceppo B/Colorado/06/2017-come: reassortant virus NYMC BX-69A derivata da B/Veneto/15/2016)

Tilgjengelig fra:

Sanofi-Aventis (Suisse) SA

ATC-kode:

J07BB02

INN (International Name):

haemagglutininum influenzae A (H1N1) (Virus strain A/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275), haemagglutinin

Legemiddelform:

sospensione iniettabile

Sammensetning:

haemagglutininum influenzae A (H1N1) (Virus souche A/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Singapore/INFIMH-16-0019/2016 (H3N2)-like: reassortant virus IVR-186) 15 µg, haemagglutininum influenzae B (Virus souche B/Colorado/06/2017-like: reassortant virus NYMC BX-69A derived from B/Maryland/15/2016) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum max. 30 µg, octoxinolum-9 max. 200 µg, neomycinum max. 7.5 pg, ovalbuminum max. 50 ng, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

Terapeutisk gruppe:

Impfstoffe

Terapeutisk område:

Immunizzazione attiva contro l'influenza, come già nel 6 ° mese

Autorisasjon dato:

1975-09-24